Erlotinib/gefitinibSkin ageing: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1622卷 / 1期

关键词：

D O I：

10.1007/s40278-016-21897-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：89 / 89

相关论文

共 50 条

[31] Erlotinib/gemcitabineInterstitial lung disease: 4 case reports
Reactions Weekly, 2015, 1543 (1) : 95 - 95
[32] Erlotinib/panitumumabOcular adverse events: 5 case reports
Reactions Weekly, 2012, 1426 (1) : 22 - 22
[33] Afatinib/erlotinib/gefitinibVarious toxicities: 22 case reports
Reactions Weekly, 2020, 1802 (1) : 16 - 16
[34] GefitinibSkin eruptions in an elderly patient: case report
Reactions Weekly, 2007, 1178 (1) : 19 - 19
[35] Erlotinib/gefitinibInterstitial lung disease: 20 case reports
Reactions Weekly, 2011, 1375 (1) : 15 - 15
[36] Erlotinib/vandetanibHypocalcaemia due to hypoparathyroidism: 2 case reports
Reactions Weekly, 2020, 1799 (1) : 170 - 170
[37] Erlotinib/osimertinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2019, 1753 (1) : 161 - 161
[38] Erlotinib/gemcitabineInterstitial lung disease: 2 case reports
Reactions Weekly, 2017, 1680 (1) : 131 - 131
[39] Erlotinib/panitumumabVarious skin toxicities: 2 case reports
Reactions Weekly, 2019, 1748 (1) : 201 - 201
[40] Erlotinib/gefitinibHair and scalp changes: 13 case reports
Reactions Weekly, 2013, 1470 (1) : 21 - 21

← 1 2 3 4 5 →